10.88EUR-1.09%Mkt Cap: —P/E: 24.121d ago
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. …
Industry Peers
Healthcare$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$348.81BUSDP/E 25.0
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$238.75BUSDP/E 27.4
$226.85BUSDP/E 33.1
$190.75BUSDP/E 11.3
$198.81BUSDP/E 36.9
$183.02BUSD
$160.96BUSDP/E 37.2
$151.78BUSDP/E 38.6
$142.49BUSDP/E 45.6
$139.84BUSDP/E 32.2
$138.11BUSDP/E 14.9
Key Statistics
Company
Market Cap—
Enterprise Value416.51M $
Revenue (TTM)2.35B $
Gross Profit215.76M $
Net Income (TTM)12.16M $
Revenue/Share95.72 USD
Last Price10.88 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees868
CountryGB
SectorHealthcare
Industry—
ISINDE000A1MMCC8
Valuation
P/E (Trailing)24.12
P/E (Forward)—
PEG—
EV/EBITDA5.50
EV/Revenue0.18
P/S—
P/B0.51
EPS (TTM)0.45
EPS (Forward)—
52W Range
10.8223% of range11.08
52W High11.08 EUR
52W Low10.82 EUR
Profitability
Gross Margin9.18%
Oper. Margin1.64%
EBITDA Margin3.22%
Profit Margin0.52%
ROE2.14%
ROA2.64%
Growth
Revenue Growth8.00%
Earnings Growth-41.50%
Cash Flow & Leverage
Operating CF43.58M $
CapEx (TTM)—
FCF Margin1.06%
FCF Yield—
Net Debt125.48M $
Net Debt/EBITDA1.66
Balance Sheet
Debt/Equity38.20
Current Ratio1.84
Quick Ratio1.30
Book Value/Sh21.73 EUR
Cash/Share3.450 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.66M
Float8.34M
Insiders19.70%
Institutions48.00%
Technical
SMA 5014.95 (-27.2%)
SMA 20015.75 (-30.9%)
Beta1.29
S&P 52W Chg20.80%
Avg Vol (30d)40.59K
Avg Vol (10d)324
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—